BYZANTINE-PAPAL RELATIONS DURING THE PONTIFICATE OF PAUL I: CONFIRMATION AND COMPLETION OF THE ROMAN REVOLUTION OF THE EIGHTH CENTURYMILLER D. H.BYZANTINISCHE ZEITSCHRIFT. 1975, Vol 68, Num 1, pp 47-62Article

THE ROMAN REVOLUTION OF THE EIGHTH CENTURY: A STUDY OF THE IDEOLOGICAL BACKGROUND OF THE PAPAL SEPARATION FROM BYZANTIUM AND ALLIANCE WITH THE FRANKSMILLER D. H.MEDIAEVAL STUDIES. 1974, Vol 36, pp 79-133Article

Magnetic resonance in monitoring the treatment of multiple sclerosisMILLER, D. H.Annals of neurology. 1994, Vol 36, pp S91-S94, issn 0364-5134, SUPConference Paper

Sacral Kingship, Biblical Kingship, and the Elevation of Pepin the Short in Religion, Culture and Society in the Early Middle Ages. Studies in Honor of Richard E. SullivanMILLER, D. H.Studies in Medieval Culture. 1987, Vol 23, pp 131-154Article

Multiple sclerosis and its treatment = Sclérose en plaque et son traitementGIOVANNON, G; MILLER, D. H.Journal of the Royal College of Physicians of London. 1999, Vol 33, Num 4, pp 315-322, issn 0035-8819Article

Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosisDALTON, C. M; BODINI, B; SAMSON, R. S et al.Multiple sclerosis. 2012, Vol 18, Num 3, pp 322-328, issn 1352-4585, 7 p.Article

Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigineHAYTON, T; FURBY, J; SMITH, K. J et al.Journal of neurology. 2012, Vol 259, Num 3, pp 505-514, issn 0340-5354, 10 p.Article

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosisO'CONNOR, P. W; GOODMAN, A; KAPPOS, L et al.Neurology. 2011, Vol 76, Num 22, pp 1858-1865, issn 0028-3878, 8 p.Article

Early MRI in optic neuritis: the risk for clinically definite multiple sclerosisSWANTON, J. K; FERNANDO, K. T; DALTON, C. M et al.Multiple sclerosis. 2010, Vol 16, Num 2, pp 156-165, issn 1352-4585, 10 p.Article

Lesion enhancement diminishes with time in primary progressive multiple sclerosisKHALEELI, Z; CICCARELLI, O; MIZSKIEL, K et al.Multiple sclerosis. 2010, Vol 16, Num 3, pp 317-324, issn 1352-4585, 8 p.Article

Spinal cord repair in MS: Does mitochondrial metabolism play a role?CICCARELLI, O; ALTMANN, D. R; MCLEAN, M. A et al.Neurology. 2010, Vol 74, Num 9, pp 721-727, issn 0028-3878, 7 p.Article

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosisALTMANN, D. R; JASPERSE, B; WAGNER, K et al.Neurology. 2009, Vol 72, Num 7, pp 595-601, issn 0028-3878, 7 p.Article

Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlierSUMMERS, M. M; FISNIKU, L. K; ANDERSON, V. M et al.Multiple sclerosis. 2008, Vol 14, Num 2, pp 197-204, issn 1352-4585, 8 p.Article

Disability and T₂ MRI lesions : a 20-year follow-up of patients with relapse onset of multiple sclerosisFISNIKU, L. K; BREX, P. A; ALTMANN, D. R et al.Brain. 2008, Vol 131, pp 808-817, issn 0006-8950, 10 p., 3Article

Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosisFURBY, J; HAYTON, T; ANDERSON, V et al.Multiple sclerosis. 2008, Vol 14, Num 8, pp 1068-1075, issn 1352-4585, 8 p.Article

Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis : a two-year longitudinal studyRASHID, W; DAVIES, G. R; CHARD, D. T et al.Multiple sclerosis. 2007, Vol 13, Num 2, pp 178-185, issn 1352-4585, 8 p.Article

Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosisBIENIEK, M; ALTMANN, D. R; DAVIES, G. R et al.Journal of neurology, neurosurgery and psychiatry. 2006, Vol 77, Num 9, pp 1036-1039, issn 0022-3050, 4 p.Article

Search for X(3872) in γγ fusion and radiative production at CLEODOBBS, S; METREVELI, Z; LOVE, W et al.Physical review letters. 2005, Vol 94, Num 3, pp 032004.1-032004.5, issn 0031-9007Article

Is inflammation important in early PPMS? a longitudinal MRI studyINGLE, G. T; SASTRE-GARRIGA, J; MILLER, D. H et al.Journal of neurology, neurosurgery and psychiatry. 2005, Vol 76, Num 9, pp 1255-1258, issn 0022-3050, 4 p.Article

Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year studySTEVENSON, V. L; INGLE, G. T; MILLER, D. H et al.Multiple sclerosis. 2004, Vol 10, Num 4, pp 398-401, issn 1352-4585, 4 p.Article

Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosisMILLER, D. H; FILIPPI, M; FAZEKAS, F et al.Annals of neurology. 2004, Vol 56, Num 2, pp 273-278, issn 0364-5134, 6 p.Article

The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MSINGLESE, M; VAN WAESBERGHE, J. H. T. M; THOMPSON, A. J et al.Neurology. 2003, Vol 60, Num 5, pp 853-860, issn 0028-3878, 8 p.Article

Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MSTRABOULSEE, A; DEHMESHKI, J; BREX, P. A et al.Neurology. 2002, Vol 59, Num 1, pp 126-128, issn 0028-3878Article

Two-year follow-up study of primary and transitional progressive multiple sclerosisINGLE, G. T; STEVENSON, V. L; KALKERS, N. F et al.Multiple sclerosis. 2002, Vol 8, Num 2, pp 108-114, issn 1352-4585Article

The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis : preliminary resultsLOSSEFF, N. A; MILLER, D. H; KIDD, D et al.Multiple sclerosis. 2001, Vol 7, Num 1, pp 23-25, issn 1352-4585Article